Cargando…
Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia
OBJECTIVES: To compare health care utilization of duloxetine initiators and pregabalin initiators among fibromyalgia patients in a real-world setting. METHODS: A retrospective cohort study was conducted based on a US national commercial health claims database (2006–2009). Fibromyalgia patients who i...
Autores principales: | Peng, X, Sun, P, Novick, D, Andrews, J, Sun, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891762/ https://www.ncbi.nlm.nih.gov/pubmed/24470771 http://dx.doi.org/10.2147/JPR.S51636 |
Ejemplares similares
-
Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia
por: Kim, Seoyoung C, et al.
Publicado: (2015) -
Comparing common reasons for inpatient and outpatient visits between commercially-insured duloxetine or pregabalin initiators with fibromyalgia
por: Zhao, Yang, et al.
Publicado: (2012) -
Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia
por: Ellis, Jeffrey J, et al.
Publicado: (2014) -
Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care
por: Andrews, Jeffrey Scott, et al.
Publicado: (2013) -
Predictors of duloxetine adherence and persistence in patients with fibromyalgia
por: Cui, Zhanglin, et al.
Publicado: (2012)